The International Sports Sciences Association (ISSA) and Life Time have expanded their partnership to offer a Guaranteed Interview Screening program for ISSA Certified Personal Trainers. This initiative creates a direct hiring pathway as trainer employment is projected to grow 7% nationwide from 2025 to 2035, with about 68,000 annual openings. Life Time is currently expanding its athletic clubs, expecting to hire hundreds of certified trainers, making this program a timely bridge from certification to career. The program is accessed through ISSA's Career Connect platform, providing job-ready trainers with streamlined interview opportunities and helping Life Time efficiently tap into a vetted talent pool.
The ISSA and Life Time partnership for a Guaranteed Interview Program is the subject here, with Pluang providing market context for health-sector stocks. Of 91 priced US health-sector stocks on Pluang, 28 rose and 59 fell. Notable movers include ACB at USD 3.92 (+2.89%), ASND at USD 258.00 (-2.61%), and INO at USD 1.21 (+2.54%) as of Sep 15, 2026 19:14 WIB.
Harmony Biosciences announced that Peter Anastasiou will become President and CEO effective January 1, 2027, succeeding Jeffrey M. Dayno, who will retire at the end of 2026. Dayno will remain as a non-executive advisor through 2027 to support the com...
Zenas BioPharma presented new data on obexelimab at the 6th International Symposium on IgG4-Related Disease, highlighting sustained clinical activity in treating IgG4-RD. Phase 3 INDIGO open-label extension results showed a high probability of patien...
The St. Louis Blues and Gray Media announced a multi-year deal to broadcast 10 select Thursday games over-the-air on ABC 32 in St. Louis and 10 other markets during the 2026-27 NHL season. This expands access to Blues games for over 4.8 million house...
Fate Therapeutics has appointed Jamie Harrell as Senior Vice President of Market Development & Commercial Operations to spearhead the commercialization of its CAR T-cell therapies, including FT819 and FT839, targeting autoimmune diseases like lupus n...
Iridex Corporation announced a two-year clinical study demonstrating that MicroPulse transscleral laser therapy significantly reduces intraocular pressure (IOP) and medication use in patients with early to advanced glaucoma. The study, involving 84 e...
